High Potency Active Pharmaceutical Ingredient (HPAPI) - Global Market Outlook (2019-2027)
According to Stratistics MRC, the Global High Potency Active Pharmaceutical Ingredient (HPAPI) Market is accounted for $20.39 billion in 2019 and is expected to reach $51.59 billion by 2027 growing at a CAGR of 12.3% during the forecast period. Rising R&D pertaining to anticancer drugs and increasing number of pharmaceutical industries are the major factors driving the market growth. However, lack of universal regulatory policies and standards is restraining the market growth.
High Potency API (HPAPI) can be defined as a pharmacologically intermediates or substances, active at concentrations of 150 micrograms per kilogram of body weight or beneath. They are generally highly selective and have the potential to bind to specific receptors or bind to specific enzymes which can cause cancer, developmental disorders, and reproductive issues at low dosages. Numerous new drugs have these high potency active pharmaceutical ingredients.
Based on application, the oncology segment is likely to have a huge demand due to rise in the introduction of advanced therapeutic options and increase in cancer cases across the globe. By geography, North America is going to have a lucrative growth during the forecast period due to the existence of developed biotech industries, rising cases of cancer, growth in rate of older age diseases along with changing lifestyle.
Some of the key players profiled in the High Potency Active Pharmaceutical Ingredient (HPAPI) Market include Abbvie, Alkermes plc, Bristol-Myers Squibb, Cambrex Corporation, Dr. Reddy's Laboratories, Eli Lilly and Company, F. Hoffmann-La Roche, Lonza Group, Novartis AG, Novasep, Pfizer, Sigma-Aldrich Co LLC, Teva Pharmaceutical Industries and WuXi AppTec.
Drug Types Covered:
Manufacturer s Covered:
• Outsourced/ Contract
• In-house (Captive)
• Infectious Diseases
• Musculoskeletal Drugs
• Other Applications
• North America
o Rest of Europe
• Asia Pacific
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2018, 2019, 2020, 2024 and 2027
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic analysis: Drivers and Constraints, Product/Technology Analysis, Porter’s five forces analysis, SWOT analysis, etc.
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Select License Type
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.